Options Trading Activity Summary - Immunovant Inc (IMVT) has seen a total options trading volume of 6,555 contracts, representing approximately 655,500 underlying shares, which is 44.2% of its average daily trading volume of 1.5 million shares over the past month. The $15 strike put option expiring on October 17, 2025, had particularly high volume with 2,804 contracts traded, representing about 280,400 underlying shares [1] - Roblox Corp (RBLX) experienced options trading volume of 39,872 contracts, equating to approximately 4.0 million underlying shares, or 43.6% of its average daily trading volume of 9.1 million shares over the past month. The $135 strike call option expiring on September 12, 2025, saw significant activity with 3,596 contracts traded, representing around 359,600 underlying shares [3] - Montrose Environmental Group Inc (MEG) recorded options trading volume of 2,070 contracts, which corresponds to approximately 207,000 underlying shares, or 43.3% of its average daily trading volume of 478,545 shares over the past month. The $40 strike call option expiring on January 16, 2026, had notable volume with 1,000 contracts traded, representing about 100,000 underlying shares [5]

Micron Technology Inc (NASDAQ:MU) stock looking to continue its win streak, up 8.2% at $151.53 at last glance and trading at 52-week highs thanks to a boost from Citigroup Securities. The firm reiterated its "buy" rating and lifted its price target to $175 from $150, citing growing demand for NAND and DRAM memory chips. On track for its seventh-consecutive daily win, MU is barreling toward its previous June 18, 2014 all-time at $157.53. Up 27.9% in September alone, the security is 80.7% higher in 2025. It's ...

Company Insights - Upstart (UPST) is an AI lending platform that assists banks in making better and faster lending decisions [4] - Over the past year, UPST shares have increased by 78%, but with significant volatility, experiencing 74 moves of 5% or more [4] - The stock price has fluctuated between a high of $96.43 in February and a low of $31.40 in April [4] Financial Projections - MarketWatch projects Upstart to earn $1.65 per share in 2025, $2.44 in 2026, and $3.06 in 2027, indicating an 85% increase over the next two years [6] - The expected price movement over the next nine days is $5.12 (8.2%), with a breakeven price of $56.81, allowing for potential profitability [6] Options Activity - On Wednesday, there was significant unusual options activity with 1,302 options traded, split 65/35 between calls and puts, indicating a bullish sentiment [1] - There were 459 unusually active put options, which could yield outsized returns for aggressive investors [2] - Specific put options with Volume-to-Open-Interest ratios over 10 could generate annualized returns exceeding 70% by selling the puts [3]

Core Insights - Deep-pocketed investors have adopted a bearish approach towards Molina Healthcare, indicating potential significant market movements ahead [1] - The options activity shows a divided sentiment among investors, with 44% bearish and only 11% bullish [2] Options Activity Summary - There have been 9 extraordinary options activities for Molina Healthcare, with a total of $391,608 in trades, including $85,226 in puts and $306,382 in calls [2] - The average open interest for options stands at 245.22, with a total volume of 812.00, indicating heightened trading interest [4] Price Projections - Significant investors are targeting a price range of $150.0 to $200.0 for Molina Healthcare over the past three months [3] - Analysts have set an average price target of $203.25, with individual targets ranging from $185 to $220 from various firms [11][12] Company Overview - Molina Healthcare focuses on Medicaid-related healthcare plans for low-income families and individuals, operating through a network of subsidiaries [10] - The company generates the majority of its revenue from the Medicaid segment, with additional segments including Medicare and Marketplace [10]

Core Insights - Investors with significant capital have adopted a bearish stance on NVIDIA, indicating potential insider knowledge of upcoming events [1] - The overall sentiment among large traders is 37% bullish and 56% bearish, with a notable disparity in the volume of call and put options [2] Options Activity - A total of 99 uncommon options trades for NVIDIA were detected, with 8 puts amounting to $354,427 and 91 calls totaling $7,005,172 [2] - Whales have targeted a price range of $125.0 to $200.0 for NVIDIA over the last three months based on volume and open interest [3] - The mean open interest for NVIDIA options trades today is 45,654.35, with a total volume of 1,987,978.00 [4] Current Position of NVIDIA - NVIDIA is recognized as a leading developer of graphics processing units (GPUs), with applications in gaming and artificial intelligence [12] - The company is expanding its data center networking solutions to enhance GPU performance for complex workloads [12] - Market experts have issued ratings for NVIDIA, with a consensus target price of $220.6, and various analysts maintaining positive ratings with target prices ranging from $205 to $235 [14][15] Stock Performance - NVIDIA's current trading volume is 25,939,745, with a price increase of 0.48%, now at $178.18 [17] - RSI readings indicate that the stock is currently neutral, positioned between overbought and oversold [17]

Group 1 - Significant bearish sentiment observed among large investors in Carvana, with 65% bearish and only 15% bullish [2] - A total of 40 uncommon options trades were identified, with puts totaling $1,110,712 and calls totaling $2,380,925 [2] - The predicted price range for Carvana over the last three months is between $50.0 and $430.0 [3] Group 2 - The mean open interest for Carvana options trades is 571.22, with a total volume of 24,209.00 [4] - Recent options activity indicates a mix of bullish and bearish trades, with notable trades including both calls and puts at various strike prices [10] - Carvana operates as an e-commerce platform for buying and selling used cars, generating revenue primarily from retail vehicle sales and additional services [11] Group 3 - Analysts have issued a consensus target price of $370.0 for Carvana, with one analyst maintaining an In-Line rating [13][14] - The current trading volume for Carvana is 2,174,757, with a price increase of 1.07%, now at $379.0 [16]

Core Insights - Investors are taking a bearish stance on Coinbase Global, with significant options activity indicating potential market movements [1][2] - The overall sentiment among large traders is 31% bullish and 49% bearish, with a notable amount of put options being traded [2] - The projected price targets for Coinbase Global range from $100.0 to $600.0 based on recent options activity [3] Options Activity - A total of 97 uncommon options trades were detected for Coinbase Global, with 22 puts totaling $1,675,913 and 75 calls totaling $6,145,384 [2] - Significant options trades include bearish puts and calls with varying strike prices and expiration dates, indicating a cautious outlook among traders [11] Market Performance - Coinbase Global's trading volume stands at 7,577,367, with the stock price currently at $315.13, reflecting a decrease of 1.15% [17] - The stock is currently neutral according to RSI indicators, suggesting it is neither overbought nor oversold [17] Company Overview - Coinbase Global, founded in 2012, is the leading cryptocurrency exchange in the U.S., focusing on being a safe entry point for retail and institutional investors [12] - The company generates most of its revenue from transaction fees and is expanding into adjacent businesses like prime brokerage and data analytics [12] Analyst Insights - An analyst from Barclays maintains an Equal-Weight rating on Coinbase Global, with an average target price of $365.0 [14][15]

Group 1 - Deep-pocketed investors have adopted a bearish approach towards Soleno Therapeutics, indicating that significant market movements may be imminent [1][2] - Among heavyweight investors, 32% are bullish while 51% are bearish, with notable options activity including 8 puts totaling $504,980 and 23 calls amounting to $1,156,660 [2] - The projected price targets for Soleno Therapeutics are between $55.0 and $70.0, based on the analysis of volume and open interest in options contracts [3] Group 2 - The average open interest for Soleno Therapeutics options is 476.88, with total volume reaching 23,916.00, indicating heightened trading activity [4] - Recent options activity includes various trades with significant total trade prices, such as a bullish put trade for $164.4K and a bearish call trade for $136.4K [9] - Soleno Therapeutics is currently trading at $61.83, down by -11.94%, with a trading volume of 5,714,276 [15] Group 3 - Soleno Therapeutics is a biopharmaceutical company focused on developing novel therapeutics for rare diseases, with its product candidate DCCR showing promise in activating KATP channels [11] - Professional analysts have set an average price target of $113.0 for Soleno Therapeutics, with varying ratings from different firms [12][13]

Core Insights - Lululemon Athletica Inc experienced an 18.1% decline in stock price, trading at $168.76, after exceeding second-quarter earnings expectations but missing revenue targets [1] - The company faces significant challenges from tariffs, estimated to impact around $240 million, leading to a reduction in fiscal third-quarter and full-year guidance [1] - Year-to-date, the stock is down 55.7%, indicating a potential for further losses as support at the $170 level weakens [2] Analyst Ratings - At least 15 firms have downgraded or lowered their price targets for Lululemon, with UBS reducing its target from $240 to $184 and Stifel downgrading to "hold" from "buy" [3] - Among the 31 analysts covering the stock, 17 have a "hold" or worse rating, reflecting a cautious outlook [3] Options Activity - Options trading has surged, with 176,000 calls and 172,000 puts traded, which is 10 times the typical volume [4] - The 50-day call/put volume ratio stands at 1.64, placing it in the 95th percentile of annual readings, indicating high levels of trading activity [4] Volatility Performance - The equity has historically outperformed volatility expectations, as indicated by a Schaeffer's Volatility Scorecard (SVS) of 98 out of 100 [5]

Core Insights - Broadcom Inc's shares increased by 11.1% to $340.21 following a strong fiscal third-quarter performance, with a new client reportedly ordering $10 billion in custom chips, speculated to be OpenAI [1][2] Financial Performance - The company reported a top- and bottom-line win for the fiscal third quarter, contributing to the stock price surge [1] - Year-to-date, Broadcom's stock has risen by 45.3% in 2024, indicating strong market performance [2] Analyst Reactions - Following the announcement, analysts issued at least 19 price-target hikes, with Melius Research raising its target from $335 to $415 [2] - A majority of brokerages, 34 out of 37, have "buy" or better ratings on Broadcom, reflecting bullish sentiment [2] Stock Performance - The stock reached an all-time high of $356.34, surpassing a recent resistance level at $325 [2] - The current trading activity indicates that Broadcom is on track for its best single-day percentage gain since April 11 [2] Options Activity - The equity has a 50-day put/call volume ratio in the 94th percentile, indicating unusual bearish sentiment among options traders prior to the stock's rise [3] - Today's options activity shows 404,000 calls and 250,000 puts traded, significantly higher than typical volume, with the most popular contract being the weekly 9/5 350-strike call [4] - Options traders are pricing in low volatility expectations, as indicated by a Schaefer's Volatility Index (SVI) of 49%, which is in the 9th percentile of the past year [4]